PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+8.78%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.32B
AUM Growth
+$2.32B
(-2.2%)
Cap. Flow
-$40.4M
Cap. Flow
% of AUM
-1.74%
Top 10 Holdings %
Top 10 Hldgs %
73.45%
Holding
41
New
1
Increased
16
Reduced
7
Closed
4
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$28.5M |
| 2 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$20.3M |
| 3 |
Insmed
INSM
|
$7.26M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$5.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$5.29M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$65.6M |
| 2 |
United Therapeutics
UTHR
|
$23.1M |
| 3 |
Amicus Therapeutics
FOLD
|
$20.4M |
| 4 |
Exact Sciences
EXAS
|
$6.42M |
| 5 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$5.57M |
Sector Composition
| 1 | Healthcare | 92.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $297M | 12.8% | 1,585,413 -349,887 | -18% | -$65.6M |
|
|
2
United Therapeutics
UTHR
$13.8B
| $238M | 10.23% | 1,606,250 -156,400 | -9% | -$23.1M |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $231M | 9.97% | 3,402,781 +73,200 | +2% | +$4.98M |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $223M | 9.59% | 2,497,806 +59,287 | +2% | +$5.29M |
|
|
5
Insmed
INSM
$28.8B
| $200M | 8.6% | 6,404,586 +232,770 | +4% | +$7.26M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $134M | 5.76% | 1,117,642 +37,300 | +3% | +$4.46M |
|
|
SAGE
7
DELISTED
Sage Therapeutics
SAGE
| $134M | 5.75% | 810,806 +23,555 | +3% | +$3.88M |
|
|
8
Amicus Therapeutics
FOLD
$2.34B
| $86.4M | 3.72% | 6,006,022 -1,414,266 | -19% | -$20.4M |
|
|
EPZM
9
DELISTED
Epizyme, Inc
EPZM
| $86.1M | 3.71% | 6,860,843 +462,547 | +7% | +$5.8M |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| $77.2M | 3.32% | 4,774,261 +1,763,795 | +59% | +$28.5M |
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $63.2M | 2.72% | 4,155,670 | – | – |
|
|
WMGI
12
DELISTED
Wright Medical Group Inc
WMGI
| $60.7M | 2.62% | 2,736,293 +59,900 | +2% | +$1.33M |
|
13
STAAR Surgical
STAA
$1.36B
| $54.2M | 2.33% | 3,496,752 -10,300 | -0.3% | -$160K |
|
14
Acadia Pharmaceuticals
ACAD
$4.38B
| $49.4M | 2.13% | 1,641,030 | – | – |
|
15
Align Technology
ALGN
$10.3B
| $47.2M | 2.03% | 212,507 -10,600 | -5% | -$2.36M |
|
|
AMAG
16
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $46.3M | 1.99% | 3,493,220 +51,987 | +2% | +$689K |
|
|
AIMT
17
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $43.4M | 1.87% | 1,146,419 -147,345 | -11% | -$5.57M |
|
18
Prothena Corp
PRTA
$441M
| $41.1M | 1.77% | 1,095,655 | – | – |
|
19
Karyopharm Therapeutics
KPTI
$61.7M
| $34M | 1.47% | 3,544,439 +45,854 | +1% | +$440K |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $32.1M | 1.38% | 307,940 +12,700 | +4% | +$1.33M |
|
|
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $25.4M | 1.09% | 1,821,576 +26,578 | +1% | +$371K |
|
|
ALDR
22
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $21.1M | 0.91% | 1,840,246 +1,775,846 | +2,758% | +$20.3M |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $21.1M | 0.91% | 135,800 +5,600 | +4% | +$869K |
|
|
24
Exact Sciences
EXAS
$8.98B
| $16.3M | 0.7% | 310,876 -122,200 | -28% | -$6.42M |
|
25
Rigel Pharmaceuticals
RIGL
$697M
| $15.3M | 0.66% | 3,935,584 +80,560 | +2% | +$313K |
|